RecruitingNot ApplicableNCT05449496
Dietary Intervention to Improve Kidney Transplant Outcomes
Sponsor
University of California, Davis
Enrollment
120 participants
Start Date
Jun 27, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
Randomized controlled trial of a curriculum intervention teaching patients to eat a whole-food plant-based dietary pattern versus standard of care in kidney transplant recipients within the first few months of transplant
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- Kidney transplant recipient aged 18 or greater
- Post-transplant months 2-12
- eGFR \>= 20 mL/min
- Have at least one of the following:
- Hypertension history (BP \>= 150/90 or on BP medications)
- Hyperglycemia history (FBG \>= 100 x 2 or on diabetes medications)
- Overweight (BMI \>= 25)
Exclusion Criteria10
- Rejection episode before study enrollment
- Gastrointestinal feeding tube or requires alternative nutrition
- Unable to understand or read English
- Unable to attend online classes or complete study questionnaires independently
- Already eating a plant-based diet
- Unwilling to make dietary changes
- Pregnant or breastfeeding
- Unable to consent
- Blindness
- Prisoners
Interventions
BEHAVIORALDietary Education Curriculum
Curriculum of dietary education and group-based counseling to encourage whole-food plant-based eating
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05449496
Related Trials
A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
NCT0724708425 locations
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731153 locations
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT0605963898 locations
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
NCT070107571 location
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
NCT052937561 location